Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States

Nav

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

01/2009 - 12/2011

Data type

Scientific literature

Keywords

Antiretroviral therapy, HIV and AIDS, HIV transmission, Health care costs, Health care economics, Health care expenditures

Citation

Authors

Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BR

Journal

Ann Intern Med

Volume

158

Issue

Pages

84-92

Publication year

2013

Suggested citation

Walensky RP, Sax PE, Nakamura YM, Weinstein MC, Pei PP, Freedberg KA, Paltiel AD, Schackman BR. Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States. Ann Intern Med. 2013; 158(2): 84-92.

DOI

10.7326/0003-4819-158-2-201301150-00002

PMID

23318310

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States

Nav